Biopsy-based predictors of prostate cancer mortality: The Mayo Model

Matthew K. Tollefson, M.D., a urologic oncologist at Mayo Clinic's campus in Rochester, Minnesota, in his article appearing in the March 2014 issue of Mayo Clinic Proceedings, using the Mayo Model, provides patients and clinicians with a novel way to predict which cases of prostate cancer, the most commonly diagnosed malignancy in American men, will be aggressive and which ones can be safely monitored with watchful waiting.

Related Videos